Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$543,081
-$1,118,707 QoQ
Shares Held
141,060
-66.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 226 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $404,338,249 across 60 Biotechnology names. MDXG ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in MDXG
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $543,081 | 141,060 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,661,788 | 420,706 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,640,320 | 685,424 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,826,627 | 404,961 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $894,974 | 146,477 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $79,458 | 10,455 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,616 | 6,405 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $199,727 | 33,795 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $64,819 | 10,036 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $359,951 | 46,747 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $415,478 | 47,375 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $228,737 | 31,377 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $189,111 | 28,610 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $89,550 | 26,261 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $56,420 | 20,295 | Shares | Sole | 2023-02-15 | |
| 2021-12-31 | $1,691 | 280 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||